Category: Child / Adolescent - Anxiety
Keywords: Child Anxiety | Depression | Primary Care
Presentation Type: Symposium
In this brief overview presentation, Dr. Weersing outlines the development of the transdiagnostic brief behavioral therapy (BBT) intervention, manual content, and implementation of the treatment in the nine pedantic clinics included in the BBT randomized controlled trial. Original trial aims are described, including the a priori plan to examine ethnicity effects in the sample. A summary of trial effects on primary outcomes is provided. In brief, BBT was markedly superior to randomization to assisted referral to care (ARC) in outpatient community mental health settings on trial primary outcomes. BBT youth had significantly higher rates of clinical response (CGI-I≤2; 57% vs.28%; χ21 = 13.09, p<.001). Doubly multivariate mixed model analysis of Pediatric Anxiety Rating Scale (PARS) and Children's Depression Rating Scale - Revised (CDRS-R) scores also significantly favored BBT (F=6.03, df=2, 160, p=.003). Follow-up tests revealed statistically significant effects for the PARS (β=-3.99 (SE=1.16), t=-3.44, df=161.37, p=.001) but not for the CDRS-R (β=-1.12 (SE=1.71), t=-0.65, df=158.43, p=.51); however, overall clinical response was not moderated by baseline level of depression. Furthermore, Latino youth (N=38) showed particularly strong response to BBT (76%) versus ARC (7%, χ21 = 14.90, p<.001). Details on treatment content and implementation and review of primary outcomes will provide the context for the following talks in the symposium based on secondary analyses from the BBT trial.
San Diego State University
Saturday, November 18
3:30 PM – 5:00 PM
The asset you are trying to access is locked. Please enter your access key to unlock.